Ernestina Tetteh

644 total citations
6 papers, 343 citations indexed

About

Ernestina Tetteh is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Ernestina Tetteh has authored 6 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 2 papers in Molecular Biology and 2 papers in Virology. Recurrent topics in Ernestina Tetteh's work include HIV/AIDS drug development and treatment (3 papers), HIV Research and Treatment (2 papers) and HIV/AIDS Research and Interventions (2 papers). Ernestina Tetteh is often cited by papers focused on HIV/AIDS drug development and treatment (3 papers), HIV Research and Treatment (2 papers) and HIV/AIDS Research and Interventions (2 papers). Ernestina Tetteh collaborates with scholars based in United States, United Kingdom and France. Ernestina Tetteh's co-authors include Daniel M. Sullivan, Johann S. de Bono, Anthony W. Tolcher, Amita Patnaik, Kyriakos P. Papadopoulos, Yan Li, L. Rhoda Molife, Lillian L. Siu, Eric X. Chen and Andrea Biondo and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Pharmacokinetics and Journal of Hematology & Oncology.

In The Last Decade

Ernestina Tetteh

6 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ernestina Tetteh United States	6	212	91	70	58	43	6	343
Madeleine Suffiotti Switzerland	9	69 0.3×	191 2.1×	92 1.3×	42 0.7×	49 1.1×	14	425
Joel Gingerich Canada	8	119 0.6×	154 1.7×	32 0.5×	72 1.2×	13 0.3×	11	316
Núria Baixeras Spain	11	111 0.5×	111 1.2×	21 0.3×	78 1.3×	27 0.6×	24	326
Tiffany Shih United States	5	106 0.5×	110 1.2×	28 0.4×	30 0.5×	21 0.5×	8	423
C Dionet France	9	159 0.8×	211 2.3×	27 0.4×	91 1.6×	60 1.4×	26	424
G Tyler United States	8	153 0.7×	62 0.7×	19 0.3×	44 0.8×	16 0.4×	13	356
Rene Costello United States	9	132 0.6×	80 0.9×	22 0.3×	13 0.2×	29 0.7×	18	290
Harekrushna Panda India	11	318 1.5×	60 0.7×	22 0.3×	32 0.6×	28 0.7×	16	549
Ron MacFarland United States	9	126 0.6×	301 3.3×	50 0.7×	18 0.3×	28 0.7×	10	573
Helen Gharwan United States	10	267 1.3×	151 1.7×	55 0.8×	38 0.7×	24 0.6×	24	477

Countries citing papers authored by Ernestina Tetteh

Since Specialization

Citations

This map shows the geographic impact of Ernestina Tetteh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ernestina Tetteh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ernestina Tetteh more than expected).

Fields of papers citing papers by Ernestina Tetteh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ernestina Tetteh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ernestina Tetteh. The network helps show where Ernestina Tetteh may publish in the future.

Co-authorship network of co-authors of Ernestina Tetteh

This figure shows the co-authorship network connecting the top 25 collaborators of Ernestina Tetteh. A scholar is included among the top collaborators of Ernestina Tetteh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ernestina Tetteh. Ernestina Tetteh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

Xu, Yingchun, et al.. (2016). Characterizing Class‐Specific Exposure‐Viral Load Suppression Response of HIV Antiretrovirals Using A Model‐Based Meta‐Analysis. Clinical and Translational Science. 9(4). 192–200. 12 indexed citations

Molife, L. Rhoda, Yan Li, Joanna Vitfell-Rasmussen, et al.. (2014). Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors. Journal of Hematology & Oncology. 7(1). 1–1. 148 indexed citations

Anderson, Matt S., Caroline Cilissen, Inge De Lepeleire, et al.. (2014). Safety, Tolerability and Pharmacokinetics of Doravirine, a Novel HIV Non-Nucleoside Reverse Transcriptase Inhibitor, after Single and Multiple doses in Healthy Subjects. Antiviral Therapy. 20(4). 397–405. 62 indexed citations

Hudis, Clifford A., Charles Swanton, Yelena Y. Janjigian, et al.. (2013). A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumors. Breast Cancer Research. 15(6). R110–R110. 85 indexed citations

Khan, Khurum, Li Yan, Amita Patnaik, et al.. (2012). A phase I dose escalation study of oral MK-2206 (allosteric Akt inhibitor) with oral selumetinib (AZD6244; ARRY-142866) (MEK 1/2 inhibitor) in patients with advanced or metastatic solid tumors.. Journal of Clinical Oncology. 30(15_suppl). e13599–e13599. 31 indexed citations

Kasserra, Claudia, Angela Sansone‐Parsons, Anther Keung, et al.. (2010). Renal Insufficiency Has No Effect on the Pharmacokinetics of Vicriviroc in a Ritonavir-Containing Regimen. Clinical Pharmacokinetics. 49(6). 397–406. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact